Life Science Investor Suits Spiked In '17, Dechert Reports
The 30 percent jump from 2016 is part of an ongoing trend, with securities cases both across the board and in life sciences consistently rising, Dechert said. Since 2012, the total number of these suits against life sciences companies has risen 225 percent, the report released Feb. 7 states.
In all, about 20 percent of securities class...
To view the full article, register now.